Journal article

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer


Authors listHardt, PD; Mazurek, S; Toepler, M; Schlierbach, P; Bretzel, RG; Eigenbrodt, E; Kloer, HU

Publication year2004

Pages980-984

JournalBritish Journal of Cancer

Volume number91

Issue number5

ISSN0007-0920

Open access statusHybrid

DOI Linkhttps://doi.org/10.1038/sj.bjc.6602033

PublisherSpringer Nature [academic journals on nature.com]


Abstract
Proliferating cells, especially tumour cells, express a special isoenzyme of pyruvate kinase, termed M2-PK, which can occur in a tetrameric form with a high affinity to its substrate, phosphoenolpyruvate (PEP), and in a dimeric form with a low PEP affinity. In tumour cells, the dimeric form is usually predominant and is therefore termed Tumour M2-PK. The levels of Tumour M2-PK within tumours and in EDTA-plasma correlate with staging and the ability of the tumour cells to metastasise. Since most colorectal tumours grow intraluminally, it appeared interesting to determine whether Tumour M2-PK is detectable in the faeces of tumour patients. Stool samples were tested by ELISA from controls without colorectal cancer and colorectal cancer patients. Whereas Tumour M2-PK levels were low in the control group (mean value+/-s.e.m.: 3.3+/-0.4, n=144), they were high in the case of colorectal cancer (56.1+/-15.3, n=60). At a cutoff value of 4 U ml(-1), the sensitivity was 73%. TNM and Dukes' classification of the tumours revealed a strong correlation between faecal Tumour M2-PK levels and staging. The determination of Tumour M2-PK in faeces provides a new promising screening tool for colorectal tumours.



Citation Styles

Harvard Citation styleHardt, P., Mazurek, S., Toepler, M., Schlierbach, P., Bretzel, R., Eigenbrodt, E., et al. (2004) Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer, British Journal of Cancer, 91(5), pp. 980-984. https://doi.org/10.1038/sj.bjc.6602033

APA Citation styleHardt, P., Mazurek, S., Toepler, M., Schlierbach, P., Bretzel, R., Eigenbrodt, E., & Kloer, H. (2004). Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. British Journal of Cancer. 91(5), 980-984. https://doi.org/10.1038/sj.bjc.6602033



Keywords


GASTROINTESTINAL-CANCERLUNG-CANCERM2-PYRUVATE KINASEMARKEROCCULT-BLOODstoolSTOOLTU M2-PKtumour M2-PKtumour screening

Last updated on 2025-10-06 at 09:31